Dr. Wechsler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 S. 9th St
Philadelphia, PA 19107Phone+1 215-829-3000
Education & Training
- Massachusetts General Hospital/Harvard Medical SchoolFellowship, Clinical Neurophysiology, 1983 - 1984
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1980 - 1984
- UPMC Medical EducationResidency, Internal Medicine, 1978 - 1980
- Perelman School of Medicine at the University of PennsylvaniaClass of 1978
Certifications & Licensure
- PA State Medical License 1979 - 2024
- NY State Medical License 2017 - 2023
- WV State Medical License 2016 - 2023
- MD State Medical License 2009 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Vascular Neurology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
- Pittsburgh Magazine Castle Connolly, 2005-2011
- Join now to see all
Clinical Trials
- Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III Start of enrollment: 2009 Jul 01
- A Study of Modified Stem Cells in Stable Ischemic Stroke Start of enrollment: 2011 Jan 01
Publications & Presentations
PubMed
- 212 citationsSafety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.David C. Hess, Lawrence R. Wechsler, Wayne M. Clark, Sean I Savitz, Gary A. Ford
The Lancet. Neurology. 2017-05-01 - 323 citationsNeuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group.S M Wolpert, H Bruckmann, R Greenlee, Lawrence R. Wechsler, Michael S. Pessin
AJNR. American Journal of Neuroradiology. 1993-01-01 - 724 citationsRecombinant tissue plasminogen activator in acute thrombotic and embolic strokeGregory J. del Zoppo, Klaus Poeck, Michael S. Pessin, Samuel M. Wolpert, Anthony J. Furlan
Annals of Neurology. 1992-07-01
Press Mentions
- This COVID-19 Practice: A Call to Limit Unnecessary Transfers to Comprehensive Stroke CentersAugust 6th, 2020
- Treat Stroke to Target Finds Lower Risk of CV Events with Lower LDL-C LevelsNovember 18th, 2019
- Lower LDL Target Better After StrokeNovember 18th, 2019
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: